• Home
  • Pregnancy &           
  • Contact us
  • Donate now
  • Frequently Asked Questions
  • Please read

Exposures in Pregnancy: Perception of Teratogenic Risk

Motherisk Research

  • Lancet. 2001 Oct 13;358(9289):1237-8.
    Jasper JD, Goel R, Einarson A, Gallo M, Koren G: Effects of framing on teratogenic risk perception in pregnant women.
  • J Clin Pharmacol. 2000 Jun;40(6):573-7.
    Pole M, Einarson A, Pairaudeau N, Einarson T, Koren G: Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals.
  • Reprod Toxicol. 1999 Jul-Aug;13(4):313-9.
    Mazzotta P, Magee LA, Maltepe C, Lifshitz A, Navioz Y, Koren G: The perception of teratogenic risk by women with nausea and vomiting of pregnancy.
  • Amer J Obstet Gynecol, 160: 1190-1194, 1989.
    Koren G, Bologa-Campeneau M, Long D, Henderson K, Feldman Y, Shear, N: Perception of teratogenic risk by pregnant women exposed to drugs and chemicals in early pregnancy.
  • Teratology 41: 657-661, 1990.
    Koren G, Pastuszak A, Pellegrini E: Prevention of unnecessary pregnancy termination by counseling women on drug, chemical and radiation exposure during the first trimester
  • Teratology 43: 109-112, 1991.
    Bentur G, Horlatch N, Koren G: Exposure to ionizing radiation during pregnancy; Perception of teratogenic risk and outcome.
  • Teratology 46: 567-571, 1992.
    Koren G, Gladstone D, Robeson C, Robieux I: The perception of teratogenic risk of cocaine.
  • November 20-21, 1990, Ottawa. Canadian Public Health Association, Health & Welfare Canada and World Health Organization.
    Koren G, Pastuszak A, Bologa M: Women's perception of teratogenic risk. Proceedings of the International Symposium on "Risk Estimation for Pharmaceuticals".
  • Can J Publ Health 82: S11-S14, 1991 No abstract available.
    Koren G, Bologa M, Pastuszak, A: Women's perception of teratogenic risk.
  • Ann N Y Acad Sci 78: 317-324, 1993. No abstract available.
    Koren G, Bologa M, Pastuszak, A: How women perceive teratogenic risk and what they do about it.
  • Koren G: Perception of teratogenic risk by women and their physicians. In: (G. Koren, ed) Folic acid for the prevention of neural tube defects. The Motherisk Program, 47-49, 1995.
  • Teratology, 40: 37-45, 1989.
    Feldman Y, Koren G, Mattice D, Shear H, Pellegrini E, MacLeod SM: Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy.
  • Reprod Toxicol. 2001 Jan;15(1):1-3. No abstract available.
    Koren G: Misrepresentation and miscommunication of teratogenic risk of drugs; analysis of three highly publicized international cases
Valid XHTML 1.0 Transitional [Valid RSS]

Motherisk is proud to be affiliated with OTIS, The Organization of Teratology Information Specialists. OTIS is a network of information services across North America.

* - "MOTHERISK - Treating the mother - Protecting the unborn" is an official mark of The Hospital for Sick Children. All rights reserved.

The information on this website is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and before you take any medications.

Copyright © 1999-2017 The Hospital for Sick Children (SickKids). All rights reserved.

The Hospital for Sick Children (SickKids) is a health-care, teaching and research centre dedicated exclusively to children; affiliated with the University of Toronto. For general inquires please call: 416-813-1500.

  |  Contact SickKids  |  Terms of Use